Press and Publications

Journalists in national and local newspapers, magazines, and books and on radio and television have documented Dr. Henkin’s work since 1959. A few of the media in which these articles appeared are listed. Please contact us for the most recent press specifics.

2018

• Primary Sjogren’s Syndrome by Henkin RI, N Engl J Med. 2018;379;97. [Editorial]

2017

• “Improved smell function with increased nasal mucus sonic hedgehog in hyposmic patients after treatment with oral theophylline” by Henkin RI, Hosein S, Stateman WA, Knöppel AB, Abdelmeguid M. Am J Otolaryngol. 2017;38:143-147. doi: 10.1016/j.amjoto.2016.11.010

• “Sonic hedgehog is present in parotid saliva and is decreased in patients with taste dysfunction” by Henkin RI, Knöppel AB, Abdelmeguid M, Stateman WA, Hosein S. J Oral Pathol Med. 2017;46:829-833. doi: 10.1111/jop.12541

• “Theophylline increases saliva sonic hedgehog and improves taste dysfunction” by Henkin RI, Knöppel AB, Abdelmeguid M, Stateman WA, Hosein S., Arch Oral Biol. 2017;82:263-270. doi: 10.1016/j.archoralbio.2017.06.022

2016

• “A genetic marker of the ACKR1 gene is present in patients with Type II congenital smell loss who have type I hyposmia and hypogeusia” by Stateman W, Knöppel AB, Flegel W, Henkin RI. Am J Otolaryngol. 2016; 37: 484-489. doi: 10.1016/j.amjoto.2015.07.0066.

• “Initiation of smell function in patients with congenital hyposmia” by Henkin RI, Abdelmeguid M and Knöppel AB. Am J Otolaryngol. 2016;37(3):175-181. 

• “On the mechanism of smell loss in patients with Type II congenital hyposmia” by Henkin RI, Abdelmeguid M and Knöppel AB. Am J Otolaryngol. Publ. Online: April 20, 2016. pii: S0196-0709(16)30005-9. doi: 10.1016/j.amjoto.2016.04.001.

• “Sonic hedgehog in nasal mucus is a biomarker for smell loss in patients with hyposmia” by Henkin RI, Hosein S, Stateman WA and Knöppel AB. Cell Mol Med. 2016, 2:2.

2015

• “Erythrocyte membrane antigen frequencies in patients with Type II congenital smell loss” by W. Stateman, R.I. Henkin, A Knöppel and W. Flegel. Am J Otolaryngol. 2015;36(2):146-152.

• Taste and smell dysfunction in the United States" by R.I. Henkin. J Oto Rhinol. 2015;4:3. [Editorial].

• “The hidden epidemic of smell loss (hyposmia) in the United States” by Henkin R. Otolaryngol Open J. 2015;1(1):e1-e2. [Editorial].

• “What is an Olfactory Hallucination”? by Henkin RI. J Epilepsy. 2015;1:e104. doi:10.4172/elj.1000e104. [Editorial].

2014

• “Repetitive transcranial magnetic stimulation (rTMS) increases plasma calcium both in vivo and in vitro” by W. Stateman, A. Knöppel, S.J. Potolicchio and R.I. Henkin.  J Clin Exp Pathol. 2014;4:187. doi:10.4172/2161-0681.1000187.

• “Effects of smell loss (hyposmia) on salt usage” by R.I. Henkin. Nutrition. 2014;30(6):690-695.

2013

• “Anatomic olfactory structural abnormalities in congenital smell loss: MRI evaluation of olfactory bulb, groove, sulcal and hippocampal morphology” by L.M. Levy, A.J. Degnan, I. Sethi and R.I. Henkin.  J Comput Assist Tomogr. 2013;37(5):650-657.

• “Interleukin 6 in hyposmia” by R.I. Henkin, L. Schmidt, and I. Velicu. JAMA Otolaryngol Head Neck Surg. 2013;139(7):728-734.

• “Olfactory hallucinations without clinical motor activity: a comparison of unirhinal with birhinal phantosmia” by R.I. Henkin, S.J. Potolicchio, and L.M. Levy. Brain Sci. 2013;3(4):1483-1553.

• “Taste and smell function in chronic disease: A review of clinical and biochemical evaluation of taste and smell dysfunction in over 5000 patients at The Taste and Smell Clinic in Washington, DC.” by R.I. Henkin, L.M. Levy and A. Fordyce. Am J Otolaryngol. 2013;34(5):477-489.

2012

• “A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders” by L. Lyckholm, S.P. Heddinger, G. Parker, P.J. Coyne, V. Ramakrishnan, T.J. Smith, and R.I. Henkin. J Pain Palliat Care Pharmacother. 2012;26(2):111-114.

• “Aetiological relationships of nasal mucus cyclic nucleotides in patients with taste and smell dysfunction” by R.I. Henkin and I. Velicu. J Clin Pathol. 2012;65(5):447-451.

• “Comparative monitoring of oral theophylline treatment in blood serum, saliva and nasal mucus” by R.I. Henkin. Ther Drug Monit. 2012;34:217-221.

• “Distinguishing patients with glossopyrosis from those with oropyrosis based upon clinical differences and differences in saliva and erythrocyte magnesium” by R.I. Henkin, V. Gouliouk, and A. Fordyce. Arch Oral Biol. 2012;57:205-210.

• “Etiological relationships of parotid saliva cyclic nucleotides in patients with taste and smell dysfunction” by R.I. Henkin and I. Velicu. Arch Oral Biol. 2012;57(6):670-677.

• “Intranasal theophylline treatment of patients with hyposmia and hypogeusia: A pilot study” by R.I. Henkin, M. Schultz and L. Minnick-Poppe. Arch Otolaryngol Head Neck Surg. 2012;138(11):1064-1070.

• “Morphological changes of the olfactory bulbs and grooves: initial report of supernumerary olfactory bulbs” by L.M. Levy, A.J. Degnan, S. Sharma, L. Kelahan, and R.I. Henkin. J Comput Assist Tomogr. 2012;36(4):406-409.

• “Vismodegib in advanced basal-cell carcinoma” by R.I. Henkin. N Engl J Med. 2012;367:970. [Letter to Editor]

2011

• Commentary on “Transcranial magnetic stimulation: a treatment for smell and taste dysfunction” by R.I. Henkin [editorial]. Am J Otolaryngol. 2011;32:178-180.

• “Differences between and within human parotid saliva and nasal mucus cAMP and cGMP in normal subjects and in patients with taste and smell dysfunction” by R.I. Henkin R.I., I. Velicu. J Oral Pathol Med. 2011;40:504-509.

• “Growth factors in olfaction” by R.I. Henkin. Preedy VR, Ed. The Handbook of Growth and Growth Monitoring in Health and Disease. Vol II. New York: Springer-Verlag; 2011, p. 1417-1436.

• “Improvement in smell and taste dysfunction after repetitive transcranial magnetic stimulation” by R.I. Henkin, S.J. Potolicchio, and L.M. Levy. American Journal of Otolaryngology, Head and Neck Surgery. 2011;32:38-46.

• “Intranasal delivery to the brain” by R. I. Henkin [editorial]. Nat Biotechnol. 2011;29:480.

• “ Relative resistance to oral theophylline treatment in patients with hyposmia manifested by decreased secretion of nasal mucus cyclic nucleotides” by R.I. Henkin, I. Velicu, and L. Schmidt. Am. J. Med. Sci. 2011;341:17-22.

2010

• “Carbonic anhydrase (CA) I, II and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation (rTMS)” by R.I. Henkin, S.J. Potolicchio, L.M. Levy, R. Moharram, I. Velicu, and B.M. Martin. Am. J. Med. Sci. 2010 339:249-257.

• “Growth factors in olfaction, in The Handbook of Growth and Growth Monitoring in Health and Disease” by R.I. Henkin. Springer Science, London, 2011, in press.

• “Intranasal Insulin – From nose to brain” by Robert I. Henkin. Nutrition. 2010 26:624-633.

• “ Inhaled Insulin – Intrapulmonary, intranasal and other routes of administration: Mechanisms of action” by Robert I. Henkin. Nutrition. 2010 26:33-39.

• “Improvement in smell and taste dysfunction after repetitive transcranial magnetic stimulation.” by R.I. Henkin, S.J. Potolicchio, and L.M. Levy. American Journal of Otolaryngology, Head and Neck Surgery. 2011;32:38-46.

2009

• “An Open Label Controlled Trial of Theophylline for Treatment of Patients with Hyposmia.”Appeared in The American Journal of the Medical Sciences. 2009. 337:396-406.

• “Decreased Parotid Salivary Cyclic Nucleotides Related to Smell Loss Severity in Patients with Taste and Smell Dysfunction” by Robert I. Henkin and Irina Velicu. Appeared in Metabolism. 2009;58:1717-1723.

• “Is Increased IL-6 the Result or Cause of Smell Loss in Patients with Hyposmia?” by Robert I. Henkin, Loren Schmidt, and Irina Velicu. Appeared in The FASEB Journal, 2009 23:835.1.

• “New Data on Human Cytokine Changes with Age” by Robert I. Henkin, Loren Schmidt, and Irina Velicu. Appeared in The FASEB Journal, 2009 23:571.9.

• “Resistance to Theophylline Therapy” by Robert I. Henkin, Loren Schmidt, and Irina Velicu. Appeared in The FASEB Journal, 2009 23:796.8.

• Taste, smell and anorexia in the aged: What can we do to help the patients? An initial primer. Appeared in Perspectives in Gerontology. American Speech, Language and Hearing Association. 2009, 13:40-64.

• “Women Respond Differently to Theophylline than do Men” by Robert I. Henkin, Irina Velicu, and Loren Schmidt . Appeared in The FASEB Journal, 2009 23:758.4.

2008

• “Taste and Appetite Loss in the Aged” by Robert I. Henkin. Appeared in Perspectives in Gerontology, American Speech, Language and Hearing Association. 2008, 13:20-32.

• “cAMP and cGMP in nasal mucus: relationships to taste and smell dysfunction, gender and age” by Robert I. Henkin and R.I. Velicu. Appeared in Clin. Invest. Med. 2008, 31:E71-E77.

• “cAMP and cGMP in nasal mucus related to severity of smell loss in patients with smell dysfunction” by Robert I. Henkin and R.I. Velicu. Appeared in Clin. Invest. Med. 2008;31:E78-E84.

2007

• “cGMP in Human Parotid Saliva: Relationships to Taste and Smell Dysfunction, Gender and Age” by Robert I. Henkin and Irina Velicu. Appeared in American Journal of Medical Science. 2007 334:6.

• “Congenital Smell Loss – a gGenetic Disorder of Decreased Cell Growth and Increased Cell Death Determined by Biochemical Measurements in Nasal Mucus” by Robert I. Henkin, Irina Velicu, and Lucien M. Levy. Appeared in The FASEB Journal. 2007 21:870.3.

• “Inhaled Insulin for Diabetes Mellitus” by Robert I. Henkin. Appeared in The New England Journal of Medicine. 2007, 356:2106-2108.

• “Measurements of Nasal Mucus cAMP and cGMP Provide Biochemical Standards for Diagnosis of Human Smell Loss” by Robert I. Henkin and Irina Velicu. Appeared in The FASEB Journal. 2007 21:870.2.

• In February, 2007, Dr. Robert I. Henkin was invited to become an Editorial Advisory Board member for Nutrition: The International Journal of Applied and Basic Sciences.

2006

• “Biochemical Basis of Human Sensory Perception” by Robert Irwin Henkin and Irina Velicu. Appeared in The FASEB Journal. 2006 20:A778.

• “Endoglin in Nasal Mucus as a Prognostic Indicator of Preeclampsia in Pregnancy” by Robert I. Henkin and Irina Velicu. Appeared in The FASEB Journal. 2006 21:870.3

• “Human Saliva and Nasal Mucus” by I. Velicu and R.I. Henkin. Appeared in Journal of Investigative Medicine, Volume 54, Issue 02, pp S373-S387. 2006 issue. (html, pdf).

• “Insulin Receptors as well as Insulin are Present in Saliva and Nasal Mucus” by R.I. Henkin and I. Velicu. Appeared in Journal of Investigative Medicine, Volume 54, Issue 02, pp S373-S387. 2006 issue. (html, pdf).

• “Measurement Standards of Smell Acuity are Necessary to Define Pathology and Treatment of Smell Loss” by Robert Irwin Henkin, Irina Velicu and Judy Winglee. Appeared in The FASEB Journal. 2006 20:A38.

• “Nasal Mucus as a Diagnostic Fluid in Human Physiology and Disease ” by Irina Velicu and Robert I. Henkin. Appeared in The FASEB Journal. 2006 21:870.5.

• “Nasal Mucus as a Prognostic Fluid in Human Physiology and Disease” by Robert I. Henkin and Irina Velicu. Appeared in The FASEB Journal. 2006 21:870.4.

2005

• “The Unbearable Absence of Smelling” by Mick O’Hare. Appeared in New Scientist, pp 42-45, September 24, 2005 issue.

• “Magnetic Stimulation Eased Burning Mouth Pain.” Appeared in Family Practice New, Volume 35, Issue 18, page 31, September 15, 2005 issue.(html, pdf).

• “Transcranial Magnetic Stimulation Eased Burning Mouth Syndrome.” Appeared in Clinical Neurology News, Volume 1, Issue 9, page 8, September 2005 issue.(html, pdf).

2003

• “Taste and Smell Disorders, Human.” Appeared in the 3rd edition of Encyclopedia of Neuroscience, November 2003 issue.